Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group

被引：0

作者：

Sebastiano Mercadante

Paolo Marchetti

Arturo Cuomo

Massimo Mammucari

Augusto Caraceni

机构：

[1] Anesthesia and Intensive Care & Pain Relief and Supportive Care,Molecular and Clinical Medicine Medical Oncology

[2] La sapienza University of Rome,Abdominal Medical Oncology

[3] National Cancer Institute Pascale,Palliative Care, Pain Therapy and Rehabilitation

[4] Primary Care Unit,Pain Relief and Palliative Care Unit

[5] ASL RME,undefined

[6] National Cancer Institute,undefined

[7] La Maddalena Cancer Center,undefined

来源：

Supportive Care in Cancer | 2016年 / 24卷

关键词：

Breakthrough pain; Opioids; Fentanyl; Morphine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.

引用

页码：961 / 968

页数：7

共 49 条

[1]

Portenoy RK(1990)Breakthrough pain: definition, prevalence and characteristics Pain 41 273-281

[2]

Hagen NA(1999)Breakthrough pain: characteristics and impact in patients with cancer pain Pain 81 129-134

[3]

Portenoy RK(2015)Italian Oncologic Pain Survey (IOPS): a multi-centre Italian study of breakthrough pain performed in different settings Clin J Pain 31 214-221

[4]

Mercadante S(2004)Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey Palliat Med 18 177-183

[5]

Caraceni A(2009)Breakthrough pain advanced cancer patients : a longitudinal study Support Care Cancer 38 554-560

[6]

Mercadante S(2010)Breakthrough pain in oncology : a longitudinal study J Pain Symptom Manag 40 183-190

[7]

Mercadante S(2013)Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients Curr Med Res Opin 29 93-97

[8]

Mercadante S(2013)Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies Curr Med Res Opin 29 667-671

[9]

Mercadante S(2012)Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI—Italian questionnaire for intense episodic pain J Pain Symptom Manag 43 833-841

[10]

Caraceni A(2011)Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients. Results from the Cancer Pain Outcome Research Study Group Clin J Pain 27 9-18

← 1 2 3 4 5 →